Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom
Figure 1
Weibull versus Kaplan-Meier survival distributions for (a) progression-free survival and (b) overall survival of pazopanib and placebo for patients in the PALETTE trial.
